Sign In
Buy LLY
$1,185.71
-7.09 (-0.594%)
At Close: Aug 07, 2026
Why Eli Lilly Deserves to Unseat Tesla Among the Magnificent 7
11:29am, Tuesday, 06'th Feb 2024
The pharmaceutical company's market cap has surpassed Tesla's, thanks to the rapid growth of its GLP-1 business.
Eli Lilly weight loss drugs are 'mega-growth assets' BMO's Evan Seigerman says
11:20am, Tuesday, 06'th Feb 2024
Eli Lilly (LLY) shares surged Tuesday morning, after the company reported strong fourth-quarter results driven by high demand for weight loss drug Zepbound and diabetes treatment Mounjaro. Evan Seiger
Eli Lilly hits record high: Here's what investors need to know
11:09am, Tuesday, 06'th Feb 2024
Jared Holz, Mizuho Securities healthcare strategist, joins 'Squawk on the Street' to discuss why supply imbalances could boost Eli Lilly's future earnings reports, if clients are asking about the comp
Eli Lilly buoyed by demand for new weight loss drug
10:46am, Tuesday, 06'th Feb 2024
Pharma giant Eli Lilly and Co said expects revenues to grow by 18% in 2024 to more than $40 billion with the surge is attributed to the growing demand for its diabetes and obesity treatments, Mounjar
Tesla Now Worth $110 Billion Less Than Weight Loss Drug Maker Eli Lilly
10:30am, Tuesday, 06'th Feb 2024
Out with electric vehicles, in with weight loss drugs: Investors have ditched one-time favorite Tesla for pharmaceutical giant Eli Lilly, as the early days of long-established Eli Lilly's diabetes and
Eli Lilly (LLY) Tops Q4 Earnings and Revenue Estimates
08:55am, Tuesday, 06'th Feb 2024
Eli Lilly (LLY) came out with quarterly earnings of $2.49 per share, beating the Zacks Consensus Estimate of $2.47 per share. This compares to earnings of $2.09 per share a year ago.
Zepbound Maker Eli Lilly Forecasts Strong Profits Amid Rollout Of Weight Loss Drug
07:41am, Tuesday, 06'th Feb 2024
Eli Lilly shares jumped in premarket Tuesday after the company reported better-than-expected fourth quarter results and revised its 2024 forecast ahead of expectations, amid soaring demand for its dia
Dow seen slightly lower but Eli Lilly jumps on earnings beat
07:07am, Tuesday, 06'th Feb 2024
7:00am: Modest falls expected; Eli Lilly jumps on earnings beat Stock futures in New York edged lower on Tuesday as investors braced for another busy day of corporate news. In pre-market trading, futu
Eli Lilly's stock surges toward a 5th straight record after an earnings beat and upbeat outlook
07:03am, Tuesday, 06'th Feb 2024
Shares of Eli Lilly and Co. LLY, +5.77% rallied toward a fifth-straight record close in premarket trading Tuesday, after the drug maker's fourth-quarter earnings beat expectations, helped by a 16% jum
Cantor Fitzgerald's Louise Chen talks what she's looking for in Eli Lilly's earnings
06:26pm, Monday, 05'th Feb 2024
Louise Chen, Cantor Fitzgerald, joins 'Fast Money' to talk Eli Lilly ahead of earnings.
3 High-Octane Growth Stocks Not Slowing Down Any Time Soon
04:14pm, Monday, 05'th Feb 2024
When finding stocks to own, growth stocks are a top priority. For those looking to invest with a truly long-term investing time horizon, growth stocks tend to outperform.
NVO, LLY or AZN: Which Pharma Stock Is the Best Weight-Loss Investment?
02:18pm, Monday, 05'th Feb 2024
Artificial intelligence grabbed most of the headlines last year, but weight loss stocks were equally noteworthy. It grew slowly for several years but really went stratospheric last year.
Markets suddenly price Eli Lilly stock for a breakout on earnings
11:17am, Monday, 05'th Feb 2024
Nowadays, the market sends mixed signals to virtually every investor attempting to participate today, squeezing out a few percentage points of gains from the stock movements. With the Federal Reserv
FDA website shows limited availability of some doses of Lilly's Mounjaro
09:36am, Monday, 05'th Feb 2024
The U.S. Food and Drug Administration's website said some doses of Eli Lilly's diabetes drug Mounjaro are available only in limited quantities through early March 2024.
After a 90% Gain, Is It Too Late to Buy Eli Lilly?
04:05am, Sunday, 04'th Feb 2024
Eli Lilly is a leader in one of the fastest-growing pharmaceutical segments today: the weight-loss market. The company recently released a new treatment specifically approved for weight management.
